Published in Cancer Weekly, May 25th, 2004
"Although it is tempting to assume that these trends are a result of earlier diagnosis and aggressive therapeutic intervention, as a consequence of prostate-specific antigen screening, definitive results from randomized trials of screening will not be available for several years," wrote J.E. Damber and colleagues, Sahlgrenska University Hospital, Department of Urology.
The researchers concluded:...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly